Health
Australians with non–small cell lung cancer (NSCLC) using tyrosine kinase inhibitors (TKIs) are invited to share their lived experience in
- Aussie ALKie
International Lung Cancer Awareness Month why not be part of a 30–60 minute interview to help with ALK+ research.
- Aussie ALKie
Short call to action referencing International Lung Cancer Awareness Month and the 30–60 minute interview.
- Aussie ALKie
